Angiogenesis in breast cancer: A comparative study of the observer variability of methods for determining microvessel density

Laboratory Investigation

Volumn 78, Issue 12, 1998, Pages 1563-1573

  Hansen, Steinbjørn ^a,c   Grabau, Dorthe A ^a,c   Rose, Carsten ^a,c   Bak, Martin ^a   Sørensen, Flemming B ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PARAMETERS; BREAST CANCER; CANCER TISSUE; COMPARATIVE STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; METHODOLOGY; MICROVASCULATURE; OBSERVER VARIATION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; TISSUE SECTION;

ANTIGENS, CD; ANTIGENS, CD34; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OBSERVER VARIATION; REGRESSION ANALYSIS;

EID: 0032422307     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Acenero MJF, Gallego MG, Ballesteros PA, and Gonzales JF (1998). Vascular density as a prognostic indicator for invasive ductal breast carcinoma. Virchows Arch 432:113-117.
2. Altman DG, De Stavola BL, Love SB, and Stepniewska KA (1995). Review of survival analyses published in cancer journals. Br J Cancer 72:511-518.
3. Axelsson K, Ljung B-ME, Moore DH II, Thor AD, Chew KL, Edgerton SM, Smith HS, and Mayall BH (1995). Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 87:997-1008.
4. Barbareschi M, Weidner N, Gasparini G, Morelli L, Forti S, Eccher C, Fina P, Caffo O, Leonardi E, Mauri F, Bevilacqua P, and Palma PD (1995). Microvessel density quantification in breast carcinomas: Assessment by light microscopy vs. a computer-aided image analysis system. Appl Immunohistochem 3:75-84.
5. Bevilacqua P, Barbareschi M, Verderio P, Boracchi P, Caffo O, Palma PD, Meli S, Weidner N, and Gasparini G (1995). Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node negative breast carcinoma: Results of a multiparametric study. Breast Cancer Res Treat 36:205-217.
6. Bland JM and Altman DG (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
7. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, and Silverman ML (1992). Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755-761.
8. Chalkley HW (1943). Method for the quantitative morphologic analysis of tissues. J Natl Cancer Inst 4:47-53.
9. Charpin C, Garcia S, Bouvier C, Martini F, Andrac L, Bonnier P, Lavaut MN, and Allasia C (1997). CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: Correlation with patient follow-up. Am J Clin Pathol 107:534-541.
10. Costello P, McCann A, Carney DN, and Dervan PA (1995). Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 26:1181-1184.
11. de Jong JS, van Diest PJ, and Baak JP (1995). Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest 73:922-926.
12. Fox SB (1997). Tumour angiogenesis and prognosis. Histopathology 30:294-301.
13. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, and Harris AL (1994). Tumor angiogenesis in node-negative breast carcinomas: Relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 29:109-116.
14. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, and Harris AL (1995a). Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177:275-283.
15. Fox SB, Turner GDH, Leek RD, Whitehouse RM, Gatter KC, and Harris AL (1995b). The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Res Treat 36:219-226.
16. Fregene TA, Khanuja PS, Gimotty PA, Kellogg C, George J, and Pienta KJ (1994). The relationship of microvessel counts to tumor size, estrogen receptor status, lymph node metastasis, and disease-free survival in patients with stage I and II breast cancer. Int J Oncol 5:1437-1445.
17. Gasparini G, Barbareschi M, Boracchi P, Bevilacqua P, Verderio P, and Dalla Palma PM-S (1995). 67-kDa laminin-receptor expression adds prognostic information to intratumoral microvessel density in node-negative breast cancer. Int J Cancer 60:604-610.
18. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, and Pozza F (1994). Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12:454-466.
19. Goulding H, Abdul Rashid NFN, Robertson JF, Bell JA, Elston CW, Blamey RW, and Ellis IO (1995). Assessment of angiogenesis in breast carcinoma: An important factor in prognosis? Hum Pathol 26:1196-1200.
20. Gundersen HJG (1977). Notes on the estimation of the numerical density of arbitrary profiles: The edge effect. J Microsc 111:219-223.
21. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sørensen FB, Vesterby A, and West MJ (1988). Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96:379-394.
22. Gundersen HJG and Østerby R (1981). Optimizing sampling efficiency of stereological studies in biology: Or "do more less well!" J Microsc 121:65-73.
23. Hall NR, Fish DE, Hunt N, Goldin RD, Guillou PJ, and Monson JR (1992). Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1:223-229.
24. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, and Hellman S (1996). Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst 88:1764-1769.
25. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, and Harris AL (1992). Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120-1124.
26. Karelia NH, Patel DD, Balar DB, Desai NS, Patel SU, Dave K, and Shah GB (1997). Prognostic significance of tumor angiogenesis in advanced breast carcinoma: An Indian experience. Neoplasma 44:163-166.
27. Kato T, Kimura T, Miyakawa R, Tanaka S, Fujii A, Yamamoto K, Kameoka S, Hamano K, Kawakami M, and Aiba M (1997). Clinicopathologic study of angiogenesis in Japanese patients with breast cancer. World J Surg 21:49-56.
28. Khanuja PS, Gimotty P, Fregene T, George J, and Pienta KJ (1993). Angiogenesis quantitation as a prognostic factor for primary breast caecinoma 2 cms or less. In: Salmon SE, editors: Adjuvant therapy of cancer. Philadelphia: Lippincott, 226-232.
29. Kohlberger PD, Obermair A, Sliutz G, Heinzl H, Koelbl H, Breitenecker G, Gitsch G, and Kainz C (1996). Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma. Am J Clin Pathol 105:705-710.
30. Kuzu I, Bicknell R, Harris AL, Jones M, Gatter KC, and Mason DY (1992). Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol 45:143-148.
31. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, and Harris AL (1996). Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625-4629.
32. Lipponen P, Ji H, Aaltomaa S, and Syrjanen K (1994). Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis. J Cancer Res Clin Oncol 120:645-650.
33. Martin L, Green B, Renshaw C, Lowe D, Rudland P, Leinster SJ, and Winstanley J (1997). Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer 76:1046-1054.
34. Morphopoulos G, Pearson M, Ryder WD, Howell A, and Harris M (1996). Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol 180:44-49.
35. Obermair A, Czerwenka K, Kurz C, Kaider A, and Sevelda P (1994). Tumoral vascular invasion in breast carcinoma: Hematoxylin-eosin versus immunohistochemical staining for factor VIII anitgen [in German]. Chirurg 65:611-615.
36. Obermair A, Kurz C, Czerwenka K, Thoma M, Kaider A, Wagner T, Gitsch G, and Sevelda P (1995). Microvessel density and vessel invasion in lymph-node-negative breast cancer: Effect on recurrence-free survival. Int J Cancer 62:126-131.
37. Ogawa Y, Chung Y-S, Nakata B, Takatsuka S, Maeda K, Sawada T, Kato Y, Yoshikawa K, Sakurai M, and Sowa M (1995). Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br J Cancer 71:1297-1301.
38. Ramani P, Bradley NJ, and Fletcher CD (1990). QBEND/10, a new monoclonal antibody to endothelium: Assessment of its diagnostic utility in paraffin sections. Histopathology 17:237-242.
39. Schlingemann RO, Rietveld FJ, De Waal RM, Bradley NJ, Skene Al, Davies AJ, Greaves MF, Denekamp J, and Ruiter DJ (1990). Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest 62:690-696.
40. Siitonen S, Haapasalo HK, Rantala IS, Helin HJ, and Isola JJ (1995). Comparison of different immunohistochemical methods in the assessment of angiogenesis: Lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol 8:745-752.
41. Simon R and Altman DG (1994). Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69:979-985.
42. Simpson JF, Ahn C, Battifora H, and Esteban JM (1996). Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 77:2077-2085.
43. Sokal RR and Rohlf FJ (1981). Biometry: The principle and practice of statistics in biological research. New York: W H Freeman and Co., 591-601.
44. Toi M, Inada K, Suzuki H, and Tominaga T (1995). Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36:193-204.
45. Toi M, Kashitani J, and Tominaga T (1993). Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55:371-374.
46. Van Hoef ME, Knox WF, Dhesi SS, Howell A, and Schor AM (1993). Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 29A:1141-1145.
47. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, Mcculloch P, Pezzella F, Viale G, Weidner N, Harris AL, and Dirix LY (1996). Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A:2474-2484.
48. Vermeulen PB, Libura J, Libura M, Hellemans PW, Van Marck E, Van Oosterom AT, and Dirix LY (1995). Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 87:1797-1798.
49. Vermeulen PB, Libura M, Libura J, O'Neill PJ, van Dam P, Van Marck E, Van Oosterom AT, and Dirix LY (1997). Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma. Breast Cancer Res Treat 42:165-172.
50. Weidner N and Folkman J (1996). Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol 167-190.
51. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, and Gasparini G (1992). Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875-1887.
52. Weidner N, Semple JP, Welch WR, and Folkman J (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8.